These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 6775008

  • 41. Detection of IgG antibodies to type-specific Pseudomonas aeruginosa lipopolysaccharides by solid-phase radioimmunoassay.
    Kohler R, White A.
    J Infect Dis; 1977 Jul; 136(1):112-6. PubMed ID: 407310
    [Abstract] [Full Text] [Related]

  • 42. Polysaccharide antigens of Pseudomonas aeruginosa.
    Pier GB.
    Rev Infect Dis; 1988 Jul; 10 Suppl 2():S337-40. PubMed ID: 3142017
    [Abstract] [Full Text] [Related]

  • 43. [Experimental study of the dynamics of the formation of protective antibodies to the antigens of the slime of Pseudomonas aeruginosa].
    Iushkova NA, Stanislavskiĭ ES, Landsman NM.
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):78-83. PubMed ID: 6405564
    [Abstract] [Full Text] [Related]

  • 44. [Evaluation of humoral immunologic response in rabbits immunized with a slime antigen of Pseudomonas aeruginosa].
    Primavera KS.
    Rev Farm Bioquim Univ Sao Paulo; 1976 Mar; 14(1):69-83. PubMed ID: 829452
    [Abstract] [Full Text] [Related]

  • 45. Pseudomonas aeruginosa vasculitis and bacteremia following conjunctivitis: a simple model of fatal pseudomonas infection in neutropenia.
    Ziegler EJ, Douglas H.
    J Infect Dis; 1979 Mar; 139(3):288-96. PubMed ID: 109545
    [Abstract] [Full Text] [Related]

  • 46. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.
    Pier GB, Sidberry HF, Sadoff JC.
    Infect Immun; 1978 Dec; 22(3):919-25. PubMed ID: 103841
    [Abstract] [Full Text] [Related]

  • 47. Evidence for Pseudomonas antigen in immune complexes in Pseudomonas osteomyelitis.
    Rahn DW, Steere AC, Grodzicki RL, Levine JH, Hardin JA.
    Arthritis Rheum; 1982 Dec; 25(12):1403-8. PubMed ID: 6816248
    [Abstract] [Full Text] [Related]

  • 48. Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.
    Lieberman MM, McKissock DC, Wright GL.
    Infect Immun; 1979 Feb; 23(2):509-21. PubMed ID: 106013
    [Abstract] [Full Text] [Related]

  • 49. Anti-lipopolysaccharide antibody levels in patients with AIDS at the onset of Pseudomonas aeruginosa bacteremia.
    Kumar PN, Collins MS, Pierce PF.
    J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):587-91. PubMed ID: 8176642
    [Abstract] [Full Text] [Related]

  • 50. [Protective effect of Pseudomonas-specific immunoglobulin from the rabbit and of active immunization in experimental Pseudomonas sepsis in mice].
    Trautmann M, Brückner O, Hahn H.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):370-83. PubMed ID: 6215803
    [Abstract] [Full Text] [Related]

  • 51. Common protective antigen between Pseudomanas aeruginosa and Vibrio cholerae.
    Yamamoto A, Homma JY, Ghoda A, Ishihara T, Takeuchi S.
    Jpn J Exp Med; 1979 Dec; 49(6):383-90. PubMed ID: 120454
    [Abstract] [Full Text] [Related]

  • 52. Serological typing of Pseudomonas aeruginosa.
    Madhubala, Shriniwas.
    Indian J Med Res; 1979 Jun; 69():926-32. PubMed ID: 112052
    [No Abstract] [Full Text] [Related]

  • 53. Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant.
    Bruins SC, Stumacher R, Johns MA, McCabe WR.
    Infect Immun; 1977 Jul; 17(1):16-20. PubMed ID: 407161
    [Abstract] [Full Text] [Related]

  • 54. Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs.
    Pennington JE, Hickey WF, Blackwood LL, Arnaut MA.
    J Clin Invest; 1981 Nov; 68(5):1140-8. PubMed ID: 6795229
    [Abstract] [Full Text] [Related]

  • 55. Effect of Pseudomonas aeruginosa lipopolysaccharide on phytohaemagglutinin induced lymphocyte transformation.
    Gallyas A, Petrás G, Adám MM, Merétey K.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):497-505. PubMed ID: 6800150
    [Abstract] [Full Text] [Related]

  • 56. [Obtaining antisera to Pseudomonas aeruginosa and Proteus antigens for performing immunoenzyme analyses in clinical practice].
    Bulava GV, Ermolin GA.
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jan; (1):51-5. PubMed ID: 3920845
    [Abstract] [Full Text] [Related]

  • 57. [Serum level of Pseudomonas aeruginosa-specific IgA in patients with chronic lower respiratory tract infection and its clinical significance].
    Tsukada H, Suzuki E, Wada K, Arakawa M.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Oct; 31(10):1227-34. PubMed ID: 8271654
    [Abstract] [Full Text] [Related]

  • 58. An antigen common to a wide range of bacteria. 2. A biochemical study of a "common antigen" from Pseudomonas aeruginosa.
    Sompolinsky D, Hertz JB, Høiby N, Jensen K, Mansa B, Pedersen VB, Samra Z.
    Acta Pathol Microbiol Scand B; 1980 Oct; 88(5):253-60. PubMed ID: 6781218
    [Abstract] [Full Text] [Related]

  • 59. Epidemiological analysis of serum anti-Pseudomonas aeruginosa PcrV titers in adults.
    Yasumoto H, Katoh H, Kinoshita M, Shimizu M, Hamaoka S, Akiyama K, Naito Y, Sawa T.
    Microbiol Immunol; 2016 Feb; 60(2):114-20. PubMed ID: 26696420
    [Abstract] [Full Text] [Related]

  • 60. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES, Lam JS.
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.